About Twist Bioscience
Twist Bioscience (NASDAQ:TWST) is a company at the forefront of synthetic biology and DNA synthesis technology. With an innovative approach to manufacturing synthetic DNA, they cater to a wide range of industries, including biopharmaceuticals, agriculture, and industrial chemicals. Twist Bioscience leverages its high-throughput DNA synthesis platform to drive advancements in drug discovery, genetic research, and biosecurity. The company's objectives encompass improving the scalability, accuracy, and speed of synthetic DNA production to empower scientists and researchers around the globe. Through their efforts, Twist Bioscience aims to address critical global challenges by enabling sustainable bio-based solutions and advancing healthcare innovations.
Snapshot
Operations
Products and/or services of Twist Bioscience
- Synthetic DNA products for various applications including research, medical, and industrial purposes.
- Next-generation sequencing (NGS) services for genetic analysis and research.
- Gene synthesis services catering to custom DNA sequence requests.
- Oligo pools for high-throughput applications in genomics and synthetic biology.
- Antibody discovery and optimization platform for therapeutic and diagnostic development.
- Biosecurity and DNA storage solutions for long-term data preservation.
Twist Bioscience executive team
- Dr. Emily Marine Leproust Ph.D.Co-Founder, Board Chair & CEO
- Dr. Patrick John Finn Ph.D.President & COO
- Mr. Adam LaponisChief Financial Officer
- Mr. Dennis Cho J.D.Chief Legal Officer & Corporate Secretary
- Ms. Paula GreenSenior Vice President of Human Resources
- Mr. Robert F. WernerVP & Chief Accounting Officer
- Mr. Siyuan ChenChief Technology Officer
- Dr. Michael Fero Ph.D.Chief Information Officer
- Ms. Nicole MorenoSenior Vice President of Sales & Support
- Mr. Jimmy JinSenior Vice President of Product & Marketing